2Liang X,Bi S,Yang W,et al.Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China.J Infect Dis,2009,200:39-47.
3Liang X,Bi S,Yang W,et al.Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.Vaccine,2009,27:6550-6557.
4Conforti A,Leone R,Ghiotto E,et al.Spontaneous reporting of drug-related hepatic reactions from two Italian regions (Lombardy and Veneto).Dig Liver Dis,2000,32:716-723.
6Ikuno N,Mackay IR,Jois J,et al.Antimitochondrial autoantibodies in saliva and sera from patients with primary biliary cirrhosis.J Gastroenterol Hepatol,2001,16:1390-1394.
7Nakamura M,Kondo H,Mori T,et al.Anti-gp210 and anticentromere antibodies are different risk factors for the progression of primary biliary cirrhosis.Hepatology,2007,45:118-127.
8Fan JG,Farrell GC.Epidemiology of non-alcoholic fatty liver disease in China.J Hepatol,2009,50:204-210.
9Fan JG.Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.J Dig Dis,2008,9:63-67.
